Background: The role of non-enzymatic antioxidants, such as uric acid, albumin, bilirubin, and α-tocopherol, in lead poisoning remains unclear. Therefore, the aim of the study was to explore the association between occupational exposure to lead and nonenzymatic antioxidant concentrations in serum and plasma. Material and Methods: The study population consisted of 278 healthy male employees of lead-zinc plants, with 129 workers classified as having low lead exposure (blood lead level -PbB = 20-39.9 μg/dl) and 149 workers classified as having high lead exposure (PbB = 40-59.8 μg/dl). The control group was composed of 73 healthy male administrative workers. No one from this group had blood lead level or zinc protoporphyrin (ZPP) level greater than normal levels, being 10 μg/dl and 2.5 μg/g of hemoglobin, respectively. In addition to the levels of PbB and ZPP, serum levels of uric acid (UA), albumin, thiol groups of albumin, and bilirubin were determined. The ferric reducing ability of plasma (FRAP) and the plasma level of α-tocopherol were also evaluated. Results: Lead exposure indices were significantly elevated in the examined subgroups as compared with the controls. Serum uric acid levels were significantly elevated in both subgroups, particularly in the group with high exposure. Serum bilirubin concentration was significantly elevated in the group with high exposure compared with the control group, while in the group with low exposure, it showed only a non-significant trend towards an increase. In contrast, ferric-reducing ability of plasma was not significantly greater in the examined subgroups as compared with the control group. Nevertheless, levels of albumin, thiol groups of albumin, and α-tocopherol levels were significantly decreased in the exposed subgroups compared with the control group. Conclusions: Occupational exposure to lead interferes with the blood non-enzymatic antioxidant system. Med Pr 2014;65(4): [443][444][445][446][447][448][449] [450] [451] 
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M. Dobrakowski et al. Nr 4 The role of other non-enzymatic antioxidants, such as uric acid, albumin, bilirubin, and α-tocopherol, in lead poisoning remains unclear. Their concentrations may be changed as a result of lead-induced dysfunctions of the kidneys, liver, or gastrointestinal tract. Alternatively, concentrations of these endogenous antioxidants may influence lead-induced oxidative stress. Recent reports concerning these interferences are inconsistent. Therefore, the present study was designed to explore the association between occupational lead exposure and non-enzymatic antioxidant concentrations in serum and plasma. This is the first study to simultaneously investigate many parameters associated with the function of the non-enzymatic antioxidant system in lead exposure.
MATERIAL AND METHODS

Study subjects
A total of 278 male employees of zinc and lead plants located in the southern region of Poland participated in the present study. The workers' mean age was 40.8±9.6 years. The mean duration of employment was 16.4±10.2 years. None of the subjects had a history of any chronic disease.
Blood concentrations of lead (PbB) and zinc protoporphyrin (ZPP) and urine delta-aminolevulinic acid (ALA) levels were measured on average every 3 months for 2 years. Mean levels of lead, ZPP and ALA in the blood and urine were calculated (PbB mean , ZPP mean , ALA mean ) using the obtained values. The examined group was divided into 2 subgroups: low exposure to lead (LE) and high exposure to lead (HE). The division was arbitrarily based on the mean concentrations of blood lead level (PbB mean ). The 1st group included 129 workers with PbB mean < 40 μg/dl (PbB mean = 20-39.9 μg/dl), and the 2nd group included 149 workers with PbB mean ≥ 40 μg/dl (PbB mean = 40.0-59.8 μg/dl).
In the final set of blood samples, in addition to the levels of PbB and ZPP, serum levels of uric acid (UA), albumin, thiol groups of albumin, and total bilirubin were determined. The ferric reducing ability of plasma (FRAP) and the plasma level of α-tocopherol were also evaluated.
INTRODUCTION
Inorganic lead is one of the earliest identified occupational toxins (1) . Sources of lead exposure include the manufacture of ammunition, batteries, sheet lead, some brass and bronze plumbing, ceramic glazes, caulking, radiation shields, circuit boards, military equipment, intravenous pumps, fetal monitors, and some surgical equipment (2) .
Lead has a strong affinity for sulfhydryl (thiol) groups and therefore may inhibit the activity of numerous enzymes, including delta-aminolevulinic acid dehydratase (ALAD). The interference with ALAD inhibits heme biosynthesis and results in ALA accumulation (delta-aminolevulinic acid). Thus, blood ALA levels could be used as a biomarker of lead exposure. The activity of ferrochelatase, the enzyme that catalyzes iron insertion into protoporphyrin IX, is also impaired by lead. This impairment causes zinc-protoporphyrin formation, which could also be used as a biomarker of lead toxicity (3) .
The physiological targets most affected by lead toxicity include the cardiovascular system, the hematopoietic system, renal and hepatic functions, the reproductive system (4), and the nervous system (5). The characteristic clinical manifestations of chronic exposure to lead include: abdominal pain, nausea, short-term memory loss, depression, loss of coordination, numbness and tingling in the extremities, constipation, inability to concentrate, and impotence (2) .
Oxidative stress has been reported to be the primary contributory agent in the pathogenesis of plumbism. Lead can not only generate reactive oxygen species (ROS), but also be able to deplete antioxidant reserves (6) . Furthermore, elevated levels of ALA, characteristic of plumbism, generate hydrogen peroxide and superoxide radicals. ALA also interacts with oxyhemoglobin. This interaction results in the generation of hydroxyl radicals, the most reactive free radicals (7) . Lead-induced oxidative stress damages various cellular components, such as proteins, lipids, and DNA (4).
Lead interferes with both the enzymatic and nonenzymatic antioxidant defenses (7, 8) .
Non-enzymatic antioxidant system in lead-exposure Nr 4 445 The control group was composed of 73 healthy male administrative workers with mean age 41.5± 9.2 years. No one from this group had PbB or ZPP levels greater than normal levels, which were 10 μg/dl and 2.5 μg/g Hgb, respectively. All of the individuals from this group had no history of occupational exposure to lead. The experimental set-up has been approved by the Bioethics Committee of the Medical University of Silesia in Katowice, Poland (Decision No. NN-6501-36/I/06).
Sampling and laboratory procedures
Blood was drawn by venipuncture. A total of 15 ml of blood from each was placed in a tube containing disodium ethylenediamine-tetraacetic acid (EDTA) solution as an anticoagulant to obtain plasma and erythrocytes, and 10 ml of blood was collected into a plain tube in order to obtain serum.
Whole blood was used to analyze levels of lead and zinc protoporphyrin. PbB levels were analyzed using graphite furnace atomic absorption spectrophotometry on Unicam 929 and 939OZ Atomic Absorption Spectrometers with GF90 and GF90Z Graphite Furnaces. Data is presented as μg/dl. Concentration of zinc protoporphyrin in the blood was measured directly using the 206 Aviv Biomedical hematofluorometer, with an excitation wavelength of 415 nm and an emission wavelength of 596 nm. The instrument measures the ratio of ZPP as a fluorescent substance to the absorption of light in the sample (hemoglobin), displayed as μg ZPP per gram of hemoglobin (μg/g Hb). Urine levels of delta-aminolevulinic acid were measured using the method of Grabecki et al. (9) and were expressed in mg/l.
After the centrifugation of the remaining whole blood, plasma was collected. Sedimented red blood cells were washed 3 times with 0.9% NaCl and then lysed with bidistilled water. The concentration of hemoglobin in a 10% hemolysate was determined by the cyanmethemoglobin method with Drabkin's reagent.
Ferric-reducing ability of plasma (FRAP) was determined by the method of Benzie and Strain (10) using the EM 280 biochemical analyzer (Emapol, Poland) at a wavelength of 593 nm. Data is shown in μmol/l. Concentrations of α-tocopherol in plasma were measured by Shearer (11) using high-performance liquid chromatography with a Spherimage 80 ODS2 column and a UV/Vis detector (Knauer, Germany). Calculations were performed using EuroChrom 2000 software (Knauer, Germany). Results are shown in μmol/l. Levels of uric acid (UA), albumin, protein and total bilirubin were measured by means of the A25 biochemical analyzer (BioSystems, Spain) according to the manufacturer's instructions. Results for UA and bilirubin are shown in μmol/l, and those for albumin and protein levels are expressed in g/l. Concentrations of thiol groups of albumin were measured according to the method of Koster et al. (12) , results are shown in μmol/g of protein.
Statistical analysis Statistica 9.1 PL software was used to perform the statistical analysis. Statistical methods included the mean and standard deviation. Levene's test was used to verify the homogeneity of variances, and Shapiro-Wilk's test was used to verify normality. Statistical comparisons were performed using Student's t-test, a t-test with separate variance estimates, or a Mann-Whitney U test. A Spearman non-parametric correlation was calculated. The value of p < 0.05 was considered to be significant.
RESULTS
The mean age, body mass index (BMI), and smoking habits were similar between the examined subgroups and the controls ( Table 1) .
The mean PbB, ZPP, and ALA were significantly elevated, by 426%, 171%, and 56%, respectively, in the LE group relative to the control group. These biomarkers were also elevated, by 623%, 317%, and 86%, respectively, in the HE group relative to the control group (Table 1) .
The serum UA levels were significantly elevated, by 7% and 16% in the LE and HE groups, respectively, in comparison to the controls. Serum bilirubin concentration was significantly elevated by 15% in the HE group compared with the control group, while in the LE group, it only showed an insignificant tendency to increase. In contrast, FRAP values were not significantly greater in the LE and HE groups as compared with the control group. The levels of albumin, thiol groups of albumin, and α-tocopherol were significantly decreased, by 4%, 12%, and 17%, respectively, in the LE group and by 6%, 13%, and 19%, respectively, in the HE group compared with the control group (Table 1, Figure 1 ).
Spearman correlation showed that there were positive correlations between the markers of lead-exposure and UA levels. Moreover, the markers in question correlated negatively with the concentrations of albumin and the thiol groups of albumin (Table 2) . BMI -body mass index / wskaźnik masy ciała, PbB -blood concentration of lead / stężenie ołowiu we krwi, ZPP -zinc protoporphyrin concentration / stężenie cynkoprotoporfiryny, ALA -delta-aminolevulinic acid concentration / stężenie kwasu delta-aminolewulinowego, FRAP -ferric-reducing ability of plasma / zdolność redukcji żelaza przez osocze, UA -concentration of uric acid / stężenie kwasu moczowego, ALB -concentration of albumin / stężenie albumin, ALB-SH -concentration of thiol groups of albumin / stężenie grup tiolowych w albuminach, BIL -concentration of bilirubin / stężenie bilirubiny, Vit. E -concentration of α-tocopherol / stężenie α-tokoferolu.
a Mean values of PbB, ZPP and ALA levels measured on average every 3 months for 2 years of observation prior to the study / Średnie wartości pomiarów stężeń PbB, ZPP i ALA wykonywanych średnio co 3 miesiące przez 2 lata obserwacji przed badaniem. Values of the last measurements of lead-exposure indices performed concomitantly with a biochemical analysis / Wartości ostatnich pomiarów markerów narażenia na ołów, które były wykonane w tym samym czasie co analiza biochemiczna.
M -mean / średnia, SD -standard deviation / odchylenie standardowe. p -in comparison to control group / w porównaniu z grupą porównawczą. p* -comparison between PbB < 40 and PbB ≥ 40 groups / porównanie między grupami PbB < 40 a PbB ≥ 40.
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DISCUSSION
Associations between lead-exposure and levels of nonenzymatic antioxidants have been studied by many researchers, however, results are inconsistent and should be verified. In the present study, many parameters associated with the function of the non-enzymatic antioxidant system have been investigated, bringing some new information, especially about the dose-effect dependence between blood lead level and antioxidant concentration.
Uric acid (UA) is the end product of purine metabolism and acts as a scavenger of peroxynitrate. As a natural antioxidant, UA accounts for up to 60% of blood antioxidative capacity (13) . UA levels in the lead-exposed subgroups were significantly elevated in a dose-dependent manner. Specifically, the increase was significantly higher in the HE group compared with the LE group.
Other human studies partially support the results of the present study. A significant increase in the UA levels in lead-exposed workers (PbB = 29.1 μg/dl) was reported in a study by Khan also found significantly increased UA levels in workers exposed to high doses of lead (PbB = 80.9 μg/dl). Consistently, a positive correlation between blood lead levels and UA concentrations was found in several studies (16) (17) (18) . Furthermore, the comparison of 2 groups of workers with PbB ≤ 60 μg/dl and PbB > 60 μg/dl showed a significant difference in the UA concentrations. The authors postulated that subjects with blood lead levels greater than 60 μg/dl had increased chances of developing adverse renal effects. However, Omae et al. (19) indicated that blood lead levels below 70 μg/dl may not be associated with adverse effects on renal function. In contrast, a study comparing aboriginals and non-aboriginals in Taiwan indicated a higher risk for renal dysfunction in people with blood lead levels exceeding 7.5 μg/dl (20) . However, unchanged UA concentrations in lead smelter workers (PbB = 46.6 μg/dl) were reported by Roels et al. (21) . Similarly, Konishi et al. (22) found no association between UA and blood lead levels in leadexposed workers (PbB = 3.9-107.7 μg/dl). These results are consistent with those of Weaver et al. (23) who also observed no association between blood lead levels and uric acid, after adjusting for age, sex, body mass index, and alcohol use. However, this study did indicate that older workers are more susceptible to the development of hyperuricemia due to lead exposure.
Despite some discrepancies among the studies described above, a dose-effect relationship between blood lead and UA levels may exist. Several mechanisms may cause increases in UA levels. High concentrations and long residence time of lead in the renal tubular epithelial cells make kidneys susceptible to lead-induced oxidative stress and inflammation (14) . Therefore, hyperuricemia may be due to increased tubular reabsorption or decreased tubular secretion of UA (17, 23) . In addition, because lead nephropathy is associated with interstitial fibrosis and glomerular sclerosis (18) , decreased glomerular filtration may result in elevated UA levels. Finally, the increase in UA concentrations may be a result of lead-induced alterations in purine metabolism. However, it should be noted that UA is known to be a nephrotoxicant (20) , and the renal pathologies that occur in plumbism could, to some extent, be secondary to hyperuricemia. Contradictory results of studies regarding the association between lead toxicity and UA level may be caused by differences in the specific materials and methods of a particular study. Such variables would determine unique combinations of the several plausible mechanisms to be triggered by lead.
The antioxidant properties of albumin are attributed to the cysteine thiol groups that determine plasma redox status. Thiol groups act as ROS scavengers and take part in thiol exchange reactions. In addition, albumin sequesters prooxidant molecules and redoxactive metals. Moreover, albumin has been proposed to have a thioredoxin-dependent lipid hydroperoxide reductase activity in vitro (13, 24) .
Concentrations of both albumin and albumin thiols were significantly decreased in the present study. Our results are supported by a study of Mikhail et al. (25) , who observed decreases in serum albumin and total protein levels, as well as a reversed albumin/globulin ratio in lead tank welders (PbB = 42.19 μg/dl). This study indicated the initial stages of fatty infiltration of the workers' livers. Khan et al. (14) also found decreased serum albumin and total protein levels in workers. However, Al-Neamy et al. (26) reported unchanged albumin and total protein levels in industrial workers exposed to lead (PbB = 77.5 μg/dl).
Reduction in albumin and protein levels may be caused by lead-induced inhibition of protein biosynthesis (27, 28) . This hypothesis was supported by Koo et al. (29) , who observed a decrease in albumin mRNA in rat liver after the administration of lead nitrate. In a study by Shalan et al. (30) , lead reduced the total RNA content in rat livers, indicating a lower rate of protein biosynthesis. One possible mechanism for this effect is that protein biosynthesis could be downregulated by lead-induced alterations in excretion of hormones, such as triiodothyronine (27) .
The decrease in albumin thiol groups in the present study was greater than the decrease in albumin. This result could have been due to the binding of lead to thiol groups and the elevated utilization of thiol groups under oxidative stress conditions. Diminished thiol contents in experimental lead exposure were reported in rats (31, 32) and calves (33) . Simultaneously, elevated parameters of lipid peroxidation were shown.
Bilirubin is an end product in heme metabolism. Heme is degraded by heme oxygenase (HO) to biliverdin, which is in turn converted to bilirubin by biliverdin reductase. Bilirubin is known to have toxic effects at high concentrations. However, under physiological conditions, bilirubin possesses strong antioxidant potential against peroxyl radicals. Bilirubin can act synergically with α-tocopherol to protect lipids from ROS (34, 35) . Noriega et al. (36) showed that bilirubin decreases ALA toxicity in rats. Decreased lipid peroxidation, increased glutathione (GSH) concentrations, and elevated Non-enzymatic antioxidant system in lead-exposure Nr 4 449 activities of antioxidant enzymes were observed in this study as a result of bilirubin administration. Serum bilirubin level was elevated in the present study. Consistent results were presented in several studies. Ibrahim et al. (27) reported elevated plasma bilirubin levels in rats that were treated with lead acetate. Similarly, when examining rats exposed to lead through intraperitoneal injections, Abdel-Moneim et al. (37) observed elevated serum bilirubin concentrations. Berrahal et al. (34) observed significantly increased plasma bilirubin levels in rats that had been injected with 15 mg/kg of lead acetate. However, lead acetate in a dose of 5 mg/kg was not sufficient to induce bilirubin level elevation. Nevertheless, in studies of Mikhail et al. (25) and Al-Neamy et al. (26) bilirubin levels showed only an insignificant tendency to increase in workers exposed to lead, whereas Khan et al. (14) reported that bilirubin concentration was not significantly decreased.
An inducible isoform of heme oxygenase is HO-1. Specific induction of HO-1 determines the adaptive response of cells to oxidative stress, especially in myocardium or nervous tissues, in which antioxidant defense is less robust (34) . Lead exposure has been confirmed to induce HO-1 activity (38, 39) . This induction is a possible explanation for elevated bilirubin levels in lead poisoning. Due to the fact that the elevation of bilirubin level was significantly higher in the HE group compared with the control group and not significantly higher in the LE group compared with the control group, it is reasonable to expect that lead induces HO-1 in a dose-dependent manner.
'Vitamin E' is a term that is used to describe at least 8 naturally occurring compounds. Alpha-tocopherol possesses the highest biological activity. Alphatocopherol interacts directly with ROS and protects biological membranes and lipoproteins from oxidative stress by limiting the propagation of lipid peroxidation. Furthermore, α-tocopherol regulates the function of the antioxidant defense system by modulating signal transduction pathways (4, 40) .
Results of the recent studies indicate that vitamin E could be useful in protecting membrane lipids from lead-induced oxidative stress. It was reported that supplementation with the vitamin may increase glutathione production and lower lipid peroxide concentrations (41) . This supplementation may also prevent the lead-induced inhibition of superoxide dismutase (SOD) and catalase (42) . Furthermore, α-tocopherol weakly increases ALAD levels in rabbits with chronic plumbism (43) .
Serum concentrations of α-tocopherol were significantly decreased in the present study. Decreased α-tocopherol concentrations were also reported in a study by Ergurhan-Ilhan et al. (42) who examined apprentices exposed to low doses of lead (PbB = 7.9±5.2 μg/dl). Moreover, Caylak et al. (44) showed decreased level of vitamin E in rats that were orally exposed to lead acetate.
The FRAP value reflects the antioxidant and reducing potentials of biological fluids (10) . Although lead induces oxidative stress, FRAP levels were unchanged in the examined subgroups. Therefore, elevated UA and bilirubin concentrations may compensate for the decreases in albumin, albumin thiols, and α-tocopherol levels, or other compensatory mechanisms may occur.
CONCLUSIONS
Occupational lead exposure interferes with the nonenzymatic antioxidant system in blood without change in the reducing capacity of plasma.
